Location:Room Milan (Hall B2, level 0)
The objective of the session is to give the urologist insight into current gold standards, controversies and future developments within andrology. The session will include basic research as well as clinical recommendations in erectile dysfunction (ED), Peyronies disease, hypogonadism and infertility. With a series of state-of-the-art and practical oriented lectures from some of the sharpest brains in andrology, this thematic session aims to both inform and inspire established -andro-urologists as well as the talents of the future.
Despite excellent oncologic outcomes, radical prostatectomy (RP) is associated with disability functional impairments, such as urinary incontinence and erectile dysfunction (ED). Despite the continuous effort in the improvement of surgical technique, nowadays up to 70% of patients still experience postoperative ED, even when a bilateral nerve-sparing approach is performed. This led to the development of several treatment options designed to improve erectile function recovery. The aim of this lecture is to provide insight into the management of patients experiencing ED after RP.
Although Hypogonadism has been recognized and treated with testosterone since more than 70 years, diagnostic criteria’s and indications for treatment are still a controversial and to some extent the discussion is a victim of emotional pro and against standpoints. The aim is to clarify real and perceived risks and hallmarks for safe and correct testosterone treatment.
Aims and objectives
Diagnosis of male infertility has been revolutionary improved resulting the significant decrease of idiopathic cases. Detailed medical history, detecting life style factors, general physical examination and semen analysis using the WHO V. criteria mean the base of the diagnostic work-up followed by imaging techniques, endocrine and genetic testing. Clarification of infectious agents and auto-immune alterations are essential part of this work. Recently developed specialized sperm functional tests and the seminal biochemical markers will lead to more precise evaluation of male infertility. The aim of this lecture is to guide the audience into the current recommendations and future directions to find therapeutic consequences treating male infertility and predict the chances of infertile couples to achieve a pregnancy.
The presentation will cover the detrimental effects of cancer treatments on male fertility and how these can be minimized. In addition fertility preservation – primarily through sperm cryopreservation – will be covered. Finally the presentation wil explore new methods for perservation and transplantation of spermatogonial sperm cells and testicular tissue.